Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor

BACKGROUND: Donor-derived malignancy is a rare complication in patients who undergo organ transplant. Approaches to treatment have largely been individualized based on clinical circumstances given the lack of evidence-based guidelines, with therapeutic options ranging from discontinuation of immunos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Ryan S., Connor, Ashton A., Inman, Brant A., Foo, Wen-Chi, Howell, David N., Madden, John F., Ellis, Matthew J., Rege, Aparna S., Harrison, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773455/
https://www.ncbi.nlm.nih.gov/pubmed/33425425
http://dx.doi.org/10.1155/2020/8881841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773455/
https://www.ncbi.nlm.nih.gov/pubmed/33425425
http://dx.doi.org/10.1155/2020/8881841

Ejemplares similares